Sign up here to receive news updates via email.
-
October 13, 2024 |
Media, News and Updates
BPGbio, University of Oxford team up on treatments for Parkinson’s
read more -
October 8, 2024 |
Media, News and Updates, Press Releases
BPGbio CEO Dr. Niven R. Narain Honored as PharmaVoice 100 Winner for Pioneering Work in AI-Driven Drug Discovery
read more -
October 7, 2024 |
Media, News and Updates, Press Releases
BPGbio and University of Oxford Enter into Strategic Collaboration Focused on Breakthrough E2-based Protein Degradation Research in Oncology and CNS Diseases
read more -
October 4, 2024 |
Media, News and Updates
My Mito Story: Living with CoQ10 Deficiency
read more -
October 2, 2024 |
Media, News and Updates, Press Releases
BPGbio to Present Novel Drug Target for Huntington’s Disease and AI Discovered Biomarkers for Alzheimer’s Disease at Society for Neuroscience 2024
read more -
September 30, 2024 |
Media, News and Updates, Press Releases
BPGbio Receives FDA Rare Pediatric Disease Designation for its Potential Treatment for Primary Coenzyme Q10 Deficiency
read more
